{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:15:29Z","timestamp":1785892529690,"version":"3.56.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016018","name":"Universidad El Bosque","doi-asserted-by":"publisher","award":["PCI-2015 8245"],"award-info":[{"award-number":["PCI-2015 8245"]}],"id":[{"id":"10.13039\/100016018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016018","name":"Universidad El Bosque","doi-asserted-by":"publisher","award":["PCI 2016\\u20138846"],"award-info":[{"award-number":["PCI 2016\\u20138846"]}],"id":[{"id":"10.13039\/100016018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejps.2023.106495","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T19:44:48Z","timestamp":1686858288000},"page":"106495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Candesartan exhibits low intrinsic permeation capacity and affects buccal tissue viability and integrity: An ex vivo study in porcine buccal mucosa"],"prefix":"10.1016","volume":"188","author":[{"given":"Yenny M.","family":"Garcia-Tarazona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Johanna","family":"Morantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Francisco Ibla","family":"Gordillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy A.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria In\u00e9s","family":"Lafaurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106495_bib0001","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40264-014-0239-7","article-title":"The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases","volume":"38","author":"Abraham","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejps.2023.106495_bib0002","doi-asserted-by":"crossref","DOI":"10.1007\/s10565-012-9212-3","article-title":"Cytoplasmic vacuolization during exposure to drugs and other substances","author":"Aki","year":"2012","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejps.2023.106495_bib0003","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2147\/DDDT.S248511","article-title":"Applying different techniques to improve the bioavailability of candesartan cilexetil antihypertensive drug","volume":"14","author":"Aly","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2023.106495_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12111047","article-title":"Enhancing the oral bioavailability of candesartan cilexetil loaded nanostructured lipid carriers: in vitro characterization and absorption in rats after oral administration","volume":"12","author":"Anwar","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106495_bib0006","first-page":"552","article-title":"Dextrans as permeation markers and carriers for oral transmucosal drug delivery","volume":"114","author":"Berka","year":"2020","journal-title":"Chem. List."},{"key":"10.1016\/j.ejps.2023.106495_bib0007","first-page":"659","article-title":"A detailed review on oral mucosal drug delivery system","volume":"3","author":"Bhati","year":"2012","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejps.2023.106495_bib0008","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0731-7085(01)00413-7","article-title":"pKa determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry","volume":"26","author":"Cagigal","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2023.106495_bib0009","series-title":"Concepts and Models for Drug Permeability Studies","first-page":"189","article-title":"Tissue-based in vitro and ex vivo models for buccal permeability studies","author":"Castro","year":"2016"},{"key":"10.1016\/j.ejps.2023.106495_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0085124","article-title":"Quantitative analysis of microbicide concentrations in fluids, gels and tissues using confocal raman spectroscopy","volume":"8","author":"Chuchuen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejps.2023.106495_bib0011","first-page":"295","article-title":"Biopharmaceutical classification of candesartan and candesartan cilexetil","volume":"2","author":"Darwhekar","year":"2012","journal-title":"Asian J. Pharm. Life Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091361","article-title":"Solid and semisolid innovative formulations containing miconazole-loaded solid lipid microparticles to promote drug entrapment into the buccal mucosa","volume":"13","author":"De Caro","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106495_bib0013","doi-asserted-by":"crossref","first-page":"E180","DOI":"10.1002\/lary.25100","article-title":"Utility of cell viability assays for use with ex vivo vocal fold epithelial tissue","volume":"125","author":"Erickson-Direnzo","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejps.2023.106495_bib0014","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpb.2008.08.016","article-title":"In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery","volume":"71","author":"Figueiras","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2023.106495_bib0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2010.10.013","article-title":"Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism","volume":"149","author":"Gao","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106495_bib0016","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/prd.12094","article-title":"Epithelial barrier and oral bacterial infection","volume":"69","author":"Groeger","year":"2015","journal-title":"Periodontology"},{"key":"10.1016\/j.ejps.2023.106495_bib0017","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jsps.2013.03.006","article-title":"Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs","volume":"22","author":"Gurunath","year":"2014","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejps.2023.106495_bib0018","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejpb.2018.10.016","article-title":"Buccal delivery of small molecules \u2013 impact of levulinic acid, oleic acid, sodium dodecyl sulfate and hypotonicity on ex vivo permeability and spatial distribution in mucosa","volume":"133","author":"Hansen","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2023.106495_bib0019","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0002-9440(10)64811-0","article-title":"Expression of alcohol dehydrogenase 3 in tissue and cultured cells from human oral mucosa","volume":"157","author":"Hedberg","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2023.106495_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0169-409X(93)90042-3","article-title":"Methods for assessing the buccal mucosa as a route of drug delivery","volume":"12","author":"Hoogstraate","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106495_bib0021","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1067\/mpr.2001.113778","article-title":"A review of saliva: normal composition, flow, and function","volume":"85","author":"Humphrey","year":"2001","journal-title":"J. Prosthet. Dent."},{"key":"10.1016\/j.ejps.2023.106495_bib0022","first-page":"12","article-title":"A review on candesartan: pharmacological and pharmaceutical profile","volume":"01","author":"Husain","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib0023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(98)00143-6","article-title":"Buccal mucosa in vitro experiments. I. confocal imaging of vital staining and MTT assays for the determination of tissue viability","volume":"58","author":"Imbert","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106495_bib0024","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MAJ.0b013e3181c94601","article-title":"Ethylene glycol, methanol and isopropyl alcohol intoxication","volume":"339","author":"Jammalamadaka","year":"2010","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib0025","first-page":"2410","article-title":"Formulation and evaluation of mucoadhesive micropsheres of candesartan","volume":"11","author":"Jena","year":"2019","journal-title":"J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejps.2023.106495_bib0026","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/odi.12043","article-title":"Influence of hypertension on pH of saliva in older adults","volume":"19","author":"Kagawa","year":"2013","journal-title":"Oral Dis."},{"key":"10.1016\/j.ejps.2023.106495_bib0027","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1208\/s12249-008-9071-7","article-title":"Effect of drug lipophilicity and ionization on permeability across the buccal mucosa: a technical note","volume":"9","author":"Kokate","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2023.106495_bib0028","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/jps.21907","article-title":"Porcine buccal mucosa as in vitro model: effect of biological and experimental variables","volume":"99","author":"Kulkarni","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib0029","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/jps.21436","article-title":"Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers","volume":"98","author":"Kulkarni","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib70","first-page":"2363","article-title":"New Hypertension Guidelines Apply to Diverse Socioeconomic Settings","volume":"323","author":"Kuehn","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejps.2023.106495_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1208\/s12249-011-9624-z","article-title":"Effect of experimental temperature on the permeation of model diffusants across porcine buccal mucosa","volume":"12","author":"Kulkarni","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2023.106495_bib0031","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/HJH.0000000000002108","article-title":"Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countries","volume":"37","author":"Lamelas","year":"2019","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejps.2023.106495_bib0032","first-page":"71","article-title":"Ex vivo permeability characteristics of porcine buccal mucosa to drugs with various polarity","volume":"35","author":"Lee","year":"2005","journal-title":"J. Korean Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104637","article-title":"Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection","author":"Loe","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejps.2023.106495_bib0034","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.07.016","article-title":"Orotransmucosal drug delivery systems: a review","volume":"140","author":"Madhav","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106495_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/membranes11090659","article-title":"Formulation and bioavailability of novel mucoadhesive buccal films for candesartan cilexetil in rats","volume":"11","author":"Mady","year":"2021","journal-title":"Membranes"},{"key":"10.1016\/j.ejps.2023.106495_bib0036","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5530\/phm.2016.7.12","article-title":"Development and characterization of buccal film of candesartan","volume":"7","author":"Malpure","year":"2016","journal-title":"Pharm. Methods"},{"key":"10.1016\/j.ejps.2023.106495_bib0037","first-page":"847","article-title":"Candesartan cilexetil various sections of the manuscript reviewed by","volume":"56","author":"Mcclellan","year":"1998","journal-title":"Adis Drug Eval."},{"key":"10.1016\/j.ejps.2023.106495_bib0038","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.tiv.2013.10.022","article-title":"A new alternative method for testing skin irritation using a human skin model: a pilot study","volume":"28","author":"Miles","year":"2014","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejps.2023.106495_bib0039","series-title":"Pathologic Basis of Veterinary Disease Expert Consult","first-page":"2","article-title":"Mechanisms and morphology of cellular injury, adaptation, and death","author":"Miller","year":"2017"},{"key":"10.1016\/j.ejps.2023.106495_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0378-5173(83)90142-4","article-title":"Permeation of estradiol through the skin - effect of vehicles","volume":"15","author":"M\u00f8llgaard","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106495_bib0041","series-title":"Biopolymer-Based Composites: Drug Delivery and Biomedical Applications","first-page":"107","article-title":"Composites of hydrogels and nanoparticles: a potential solution to current challenges in buccal drug delivery","author":"Morantes","year":"2017"},{"key":"10.1016\/j.ejps.2023.106495_bib0042","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10837459609022593","article-title":"Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation","volume":"1","author":"Nakane","year":"1996","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2023.106495_bib0043","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/acs.molpharmaceut.2c00124","article-title":"Mechanisms and extent of enhanced passive permeation by colloidal drug particles","volume":"19","author":"Narula","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2023.106495_bib0044","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/10837450802585278","article-title":"Development and characterization of solid oral dosage form incorporating candesartan nanoparticles Solid oral dosage form incorporating drug nanoparticles","volume":"14","author":"Nekkanti","year":"2009","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2023.106495_bib0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jps.20240","article-title":"Enhanced buccal mucosal retention and reduced buccal permeability of estradiol in the presence of padimate O and Azone\u00ae: a mechanistic study","volume":"94","author":"Nicolazzo","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib0046","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jps.10559","article-title":"Assessment of the effects of sodium dodecyl sulfate on the buccal permeability of caffeine and estradiol","volume":"93","author":"Nicolazzo","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111848","article-title":"Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth","volume":"185","author":"Ni","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106495_bib0047","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/jps.10505","article-title":"The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa","volume":"92","author":"Nicolazzo","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106495_bib0048","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(99)00368-3","article-title":"TR146 cells grown on filters as a model of human buccal epithelium: IV. permeability of water, mannitol, testosterone and \u03b2-adrenoceptor antagonists. comparison to human, monkey and porcine buccal mucosa","volume":"194","author":"Nielsen","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106495_bib0049","first-page":"3827","article-title":"Formulation development and evaluation of candesartan buccal tablets","volume":"9","author":"Padmaja","year":"2018","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejps.2023.106495_bib0050","first-page":"330","article-title":"Preformulation study for candesartan cilexetil buccal (Effervescent) tablet","volume":"8","author":"Pansuriya","year":"2019","journal-title":"Pharma Innov. J."},{"key":"10.1016\/j.ejps.2023.106495_bib0051","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/joor.12664","article-title":"Salivary secretion in health and disease","volume":"45","author":"Pedersen","year":"2018","journal-title":"J. Oral Rehabil."},{"key":"10.1016\/j.ejps.2023.106495_bib0052","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1754-4505.1998.tb00907.x","article-title":"Oral health and medical status in dentate low-income older persons","volume":"18","author":"Persson","year":"1998","journal-title":"Spec. Care Dent."},{"key":"10.1016\/j.ejps.2023.106495_bib0053","first-page":"1700","article-title":"Design and characterization of buccal patches of candesartan cilexetil","volume":"7","author":"Reddy","year":"2018","journal-title":"World J. Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106495_bib0054","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/17435390.2011.580863","article-title":"Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa","volume":"6","author":"Roblegg","year":"2012","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.ejps.2023.106495_bib0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ddtec.2005.05.018","article-title":"Buccal drug delivery: a challenge already won?","volume":"2","author":"Rossi","year":"2005","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejps.2023.106495_bib0056","doi-asserted-by":"crossref","first-page":"35","DOI":"10.22270\/jddt.v11i1-s.4547","article-title":"Muco-adhesive buccal tablets of candesartan cilexetil for oral delivery: preparation, in-vitro and ex-vivo evaluation","volume":"11","author":"Samanthula","year":"2021","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.ejps.2023.106495_bib0057","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.5958\/0974-360X.2019.00514.6","article-title":"Development, in-vitro and ex-vivo evaluation of muco-adhesive buccal patches of candesartan cilexetil","volume":"12","author":"Samanthula","year":"2019","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.ejps.2023.106495_bib0058","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-3659(01)00269-3","article-title":"Drug permeation enhancement via buccal route: possibilities and limitations","volume":"72","author":"\u015eenel","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106495_bib0059","doi-asserted-by":"crossref","unstructured":"Sharma M., Sharma R., Jain D.K., 2016. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica (Cairo) 2016. 10.1155\/2016\/8525679.","DOI":"10.1155\/2016\/8525679"},{"key":"10.1016\/j.ejps.2023.106495_bib0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5958\/0974-360X.2016.00105.0","article-title":"Preparation and characterization of microwave-assisted candesartan cilexetil solid dispersions","volume":"9","author":"Sonawane","year":"2016","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.ejps.2023.106495_bib0061","first-page":"125","article-title":"Design and evaluation of controlled release mucoadhesive buccal tablets of Candesartan. IJPI's","volume":"1","author":"Thulluru","year":"2011","journal-title":"J. Pharm. Cosmetol."},{"key":"10.1016\/j.ejps.2023.106495_bib0062","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.archoralbio.2003.12.002","article-title":"Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa","volume":"49","author":"Van Eyk","year":"2004","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejps.2023.106495_bib0063","first-page":"56","article-title":"Formulation and evaluation of mucoadhesive buccal tablets of candesartan","volume":"5","author":"Vinay","year":"2015","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.ejps.2023.106495_bib0064","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1208\/s12248-010-9227-8","article-title":"Application of method suitability for drug permeability classification","volume":"12","author":"Volpe","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2023.106495_bib0065","article-title":"A method for evaluating drug penetration and absorption through isolated buccal mucosa with highly accuracy and reproducibility","author":"Wang","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2023.106495_bib0066","article-title":"Types and evaluation of in vitro penetration models for buccal mucosal delivery","volume":"61","author":"Wang","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2023.106495_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2021.688772","article-title":"Repurposing candesartan cilexetil as antibacterial agent for MRSA infection","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejps.2023.106495_bib0068","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1369\/0022155418812405","article-title":"Impaired junctions and invaded macrophages in oral epithelia with oral pain","volume":"67","author":"Yoshimoto","year":"2019","journal-title":"J. Histochem. Cytochem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:56:50Z","timestamp":1778558210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":69,"alternative-id":["S0928098723001252"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106495","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candesartan exhibits low intrinsic permeation capacity and affects buccal tissue viability and integrity: An ex vivo study in porcine buccal mucosa","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106495"}}